Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy.

CTG repeat expansions MBNL1 protein alternative splicing antisense oligonucleotide microRNAs myotonic dystrophy therapeutic gene modulation tissue distribution transcriptomics

Journal

Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621

Informations de publication

Date de publication:
03 Dec 2021
Historique:
received: 18 10 2020
accepted: 17 07 2021
entrez: 13 9 2021
pubmed: 14 9 2021
medline: 14 9 2021
Statut: epublish

Résumé

Myotonic dystrophy type 1 (DM1) is a rare neuromuscular disease caused by expansion of unstable CTG repeats in a non-coding region of the

Identifiants

pubmed: 34513303
doi: 10.1016/j.omtn.2021.07.017
pii: S2162-2531(21)00185-2
pmc: PMC8413838
doi:

Types de publication

Journal Article

Langues

eng

Pagination

174-191

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

B.L., R.A., J.M.F.-C., and E.C.-H. are inventors in patent PCT/EP2017/073685. This patent is currently licensed to Arthex Biotech, of which B.L. and R.A. are founders and CEO and scientific consultant, respectively. B.L. and R.A. each hold more than 5% ownership of Arthex, a company with related interests.

Références

Nucleic Acid Ther. 2015 Oct;25(5):275-84
pubmed: 26176274
Biostat Bioinforma Biomath. 2013 Aug;3(3):71-85
pubmed: 25558171
Mol Ther Nucleic Acids. 2020 Sep 4;21:837-849
pubmed: 32805487
Nat Protoc. 2014 Sep;9(9):2045-60
pubmed: 25079428
J Clin Invest. 2012 Dec;122(12):4461-72
pubmed: 23160194
Hum Mol Genet. 2013 Feb 15;22(4):704-16
pubmed: 23139243
Science. 2000 Sep 8;289(5485):1769-73
pubmed: 10976074
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nucleic Acids Res. 2008 Jan;36(Database issue):D165-9
pubmed: 18029362
Mol Cell. 2002 Jul;10(1):45-53
pubmed: 12150906
Nat Struct Mol Biol. 2010 Feb;17(2):187-93
pubmed: 20098426
Oncol Rep. 2015 May;33(5):2606-12
pubmed: 25812649
Cell Tissue Res. 2015 Jun;360(3):591-608
pubmed: 25358400
Rare Dis. 2013 Sep 26;1:e26555
pubmed: 25003008
Differentiation. 2008 Mar;76(3):299-309
pubmed: 17697127
Exp Cell Res. 2015 May 15;334(1):173-82
pubmed: 25857406
Cell Death Dis. 2020 Jul 18;11(7):545
pubmed: 32683410
Proc Natl Acad Sci U S A. 2019 Dec 10;116(50):25203-25213
pubmed: 31754023
Sci Rep. 2016 Apr 29;6:25317
pubmed: 27126921
Clin Transl Sci. 2015 Aug;8(4):298-304
pubmed: 26011798
Neurol Clin Pract. 2018 Dec;8(6):507-520
pubmed: 30588381
Adv Drug Deliv Rev. 2015 Jun 29;87:46-51
pubmed: 25666165
Nat Biotechnol. 2019 Jun;37(6):640-650
pubmed: 31036929
Hum Mol Genet. 2015 Sep 1;24(17):4971-83
pubmed: 26082468
J Biol Chem. 2001 Mar 16;276(11):7820-6
pubmed: 11124939
Nucleic Acids Res. 2020 Jan 8;48(D1):D148-D154
pubmed: 31647101
Dis Model Mech. 2017 Apr 1;10(4):487-497
pubmed: 28188264
Proc Natl Acad Sci U S A. 2020 Mar 10;117(10):5472-5477
pubmed: 32086392
Mol Cell Biol. 2019 Oct 11;39(21):
pubmed: 31383751
Cell. 1992 Apr 17;69(2):385
pubmed: 1568252
Nat Commun. 2018 Jun 26;9(1):2482
pubmed: 29946070
Sci Rep. 2020 Feb 13;10(1):2558
pubmed: 32054946
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Genes Cells. 2007 Sep;12(9):1035-48
pubmed: 17825047
Cell Physiol Biochem. 2018;48(1):339-347
pubmed: 30016774
Mol Cell. 2007 Oct 12;28(1):68-78
pubmed: 17936705
J Pharmacol Exp Ther. 2015 Nov;355(2):329-40
pubmed: 26330536
Nucleic Acids Res. 2017 Feb 28;45(4):1760-1775
pubmed: 27903900
Hum Mol Genet. 2019 Apr 15;28(8):1312-1321
pubmed: 30561649
Hum Mol Genet. 2009 Apr 15;18(8):1471-81
pubmed: 19223393
Hum Mol Genet. 2020 Aug 3;29(13):2185-2199
pubmed: 32504084
Environ Health Perspect. 2009 Feb;117(2):231-40
pubmed: 19270793
Hum Mol Genet. 2012 Nov 1;21(21):4645-54
pubmed: 22846424
Nat Commun. 2015 Jul 27;6:7718
pubmed: 26212498
Science. 2009 Jul 17;325(5938):336-9
pubmed: 19608921
Mol Cell. 2010 Jun 25;38(6):789-802
pubmed: 20620952
Nat Cell Biol. 2005 Dec;7(12):1240-7
pubmed: 16273094
Nat Struct Mol Biol. 2011 Jun 19;18(7):840-5
pubmed: 21685920
PLoS One. 2018 Oct 18;13(10):e0206239
pubmed: 30335862
Hum Mol Genet. 2017 Aug 15;26(16):3056-3068
pubmed: 28535287
Curr Treat Options Neurol. 2016 Dec;18(12):52
pubmed: 27826760
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Science. 2003 Dec 12;302(5652):1978-80
pubmed: 14671308
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
EMBO J. 2000 Sep 1;19(17):4439-48
pubmed: 10970838
Nucleic Acids Res. 2020 Jan 8;48(D1):D127-D131
pubmed: 31504780
Nucleic Acids Res. 2001 Jul 1;29(13):2766-71
pubmed: 11433021
Nature. 2011 Oct 05;478(7367):123-6
pubmed: 21979052
Hum Mol Genet. 2006 Jul 1;15(13):2087-97
pubmed: 16717059
Sci Rep. 2016 Nov 02;6:36230
pubmed: 27805016
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11748-53
pubmed: 16864772
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4221-6
pubmed: 22371589
Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):10962-7
pubmed: 27621445
Cell. 2012 Aug 17;150(4):710-24
pubmed: 22901804
Nucleic Acids Res. 2009 Jan;37(Database issue):D105-10
pubmed: 18996891
Mol Cell. 2014 Oct 23;56(2):311-322
pubmed: 25263597
Science. 1992 Mar 6;255(5049):1253-5
pubmed: 1546325
Sci Transl Med. 2020 Apr 29;12(541):
pubmed: 32350131
Neuron. 2012 Aug 9;75(3):437-50
pubmed: 22884328
Mol Ther Nucleic Acids. 2020 Mar 6;19:278-292
pubmed: 31855836
Sci Rep. 2012;2:209
pubmed: 22355723
Genome Res. 2015 Jun;25(6):858-71
pubmed: 25883322
EMBO Mol Med. 2013 Dec;5(12):1887-900
pubmed: 24293317
Nat Med. 2011 Jun;17(6):720-5
pubmed: 21623381

Auteurs

Estefanía Cerro-Herreros (E)

University Research Institute for Biotechnology and Biomedicine (BIOTECMED), Universidad de Valencia, Dr. Moliner, 50, 46100 Burjasot, Valencia, Spain.
Incliva Biomedical Research Institute, Avenida Menéndez Pelayo 4 acc, 46010 Valencia, Spain.

Irene González-Martínez (I)

University Research Institute for Biotechnology and Biomedicine (BIOTECMED), Universidad de Valencia, Dr. Moliner, 50, 46100 Burjasot, Valencia, Spain.
Incliva Biomedical Research Institute, Avenida Menéndez Pelayo 4 acc, 46010 Valencia, Spain.

Nerea Moreno (N)

University Research Institute for Biotechnology and Biomedicine (BIOTECMED), Universidad de Valencia, Dr. Moliner, 50, 46100 Burjasot, Valencia, Spain.
Incliva Biomedical Research Institute, Avenida Menéndez Pelayo 4 acc, 46010 Valencia, Spain.

Jorge Espinosa-Espinosa (J)

University Research Institute for Biotechnology and Biomedicine (BIOTECMED), Universidad de Valencia, Dr. Moliner, 50, 46100 Burjasot, Valencia, Spain.
Incliva Biomedical Research Institute, Avenida Menéndez Pelayo 4 acc, 46010 Valencia, Spain.

Juan M Fernández-Costa (JM)

University Research Institute for Biotechnology and Biomedicine (BIOTECMED), Universidad de Valencia, Dr. Moliner, 50, 46100 Burjasot, Valencia, Spain.
Incliva Biomedical Research Institute, Avenida Menéndez Pelayo 4 acc, 46010 Valencia, Spain.

Anna Colom-Rodrigo (A)

University Research Institute for Biotechnology and Biomedicine (BIOTECMED), Universidad de Valencia, Dr. Moliner, 50, 46100 Burjasot, Valencia, Spain.
Incliva Biomedical Research Institute, Avenida Menéndez Pelayo 4 acc, 46010 Valencia, Spain.

Sarah J Overby (SJ)

University Research Institute for Biotechnology and Biomedicine (BIOTECMED), Universidad de Valencia, Dr. Moliner, 50, 46100 Burjasot, Valencia, Spain.
Incliva Biomedical Research Institute, Avenida Menéndez Pelayo 4 acc, 46010 Valencia, Spain.

David Seoane-Miraz (D)

Department of Paediatrics, University of Oxford, John Radcliffe Hospital, Headley Way, OX3 9DU, Oxford, UK.
MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, UK.

Javier Poyatos-García (J)

The IISLAFE Health Research Institute, Avenida Fernando Abril Martorell, 106 Torre A 7 planta, 46026 Valencia, Spain.
Neuromuscular Reference Centre ERN EURO-NMD and Neuromuscular Pathology and Ataxia Research Group, Hospital La Fe Health Research Institute, Valencia, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.

Juan J Vilchez (JJ)

The IISLAFE Health Research Institute, Avenida Fernando Abril Martorell, 106 Torre A 7 planta, 46026 Valencia, Spain.
Neuromuscular Reference Centre ERN EURO-NMD and Neuromuscular Pathology and Ataxia Research Group, Hospital La Fe Health Research Institute, Valencia, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.

Adolfo López de Munain (A)

Biodonostia Health Research Institute, P° Dr. Beguiristain s/n, 20014 Donostia-San Sebastián, Spain.
Hospital Universitario Donostia-Osakidetza-Departamento de Neurociencias-Universidad del Pais Vasco-CIBERNED.

Miguel A Varela (MA)

Department of Paediatrics, University of Oxford, John Radcliffe Hospital, Headley Way, OX3 9DU, Oxford, UK.
MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, UK.

Matthew J Wood (MJ)

Department of Paediatrics, University of Oxford, John Radcliffe Hospital, Headley Way, OX3 9DU, Oxford, UK.
MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, UK.

Manuel Pérez-Alonso (M)

University Research Institute for Biotechnology and Biomedicine (BIOTECMED), Universidad de Valencia, Dr. Moliner, 50, 46100 Burjasot, Valencia, Spain.
Incliva Biomedical Research Institute, Avenida Menéndez Pelayo 4 acc, 46010 Valencia, Spain.

Beatriz Llamusí (B)

University Research Institute for Biotechnology and Biomedicine (BIOTECMED), Universidad de Valencia, Dr. Moliner, 50, 46100 Burjasot, Valencia, Spain.
Incliva Biomedical Research Institute, Avenida Menéndez Pelayo 4 acc, 46010 Valencia, Spain.

Rubén Artero (R)

University Research Institute for Biotechnology and Biomedicine (BIOTECMED), Universidad de Valencia, Dr. Moliner, 50, 46100 Burjasot, Valencia, Spain.
Incliva Biomedical Research Institute, Avenida Menéndez Pelayo 4 acc, 46010 Valencia, Spain.

Classifications MeSH